CSL BEHRING is a finished-dose manufacturer based in Switzerland. It holds one valid CEP. Its filings concentrate with EMA, AIFA (IT) and Health Canada. Its GMP standing is certified by ZLG (DE), EMA and ANVISA (Brazil), among 5 authorities. Its most recent recorded inspection, by US FDA, closed on 2 March 2023 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Bern, United Arab Emirates | Not on file |
| Bern, United Arab Emirates | Not on file |
| 35041 Marburg, United Arab Emirates | Not on file |
| BERN (BERNA), Switzerland | Not on file |
| Bern, Switzerland | Not on file |
| Switzerland, Switzerland | 3002806716 |
6 further sites are on record.
| Molecule | Regulators | Docs |
|---|---|---|
| Water For Injections | EDQM | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| EMA | 136 | 6 |
| AIFA (IT) | 115 | None |
| Health Canada | 115 | None |
| FAMHP (BE) | 87 | None |
| INFARMED (PT) | 63 | None |
| MEDSAFE (NZ) | 61 | None |
| ZLG (DE) | None | 8 |
| ANVISA (Brazil) | None | 4 |
| HSA (SG) | None | 1 |
| EAEU_EEC | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2023 | $30.0B | Not reported | Not reported |
| 2022 | $20.0B | Not reported | Not reported |
| 2021 | $20.0B | Not reported | Not reported |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. CSL BEHRING comes back tiered against every other supplier able to file there.
Start for free